Bio-Logic is a global leader for high precision potentiostats/galvanostats and multipotentiostats, battery cyclers and electrochemical scanning systems for more than 20 years. We provide integrated EIS systems, either in multi-channels formats for battery cyclers or single portable potentiostats. Our leadership in the energy testing is balanced by our ability to explore low current as well for analytics and sensors investigations. Powerful BT/EC-Lab & BT-suite software platform proposes all kind of electrochemical tests procedure with builtin calculations tools. All our products are developed and designed in Seyssinet-Pariset, France. Bio-Logics skill is dedicated to strong support and relies on our optimized partners distribution network. We invite you to especially learn more about our BCS range.
BioGenesis PR
While Puerto Rico’s academic institutions count with their own research infrastructures and resources, we understand that there is a need for a fresh, innovative update to these. Furthermore, there are limited opportunities outside of academic institutions for researchers to expand their horizons, take their scientific efforts out of academia and enter the Biotechnology industry. We are a Biotechnology and Life Sciences incubator underway to stand as a beacon of innovation, dedicated to fortifying Puerto Rico’s position as a vibrant hub for groundbreaking advancements. Our mission is clear; to catalyze the growth of research-driven initiatives and contribute significantly to Puerto Rico’s research landscape. By providing state-of-the-art facilities, fostering interdisciplinary collaborations, and offering strategic mentorship, we aim to drive economic growth, attract professional talents, create high-impact opportunities, and fortify Puerto Rico as a global leader in the life sciences and technology arena. Our vision is ambitious yet attainable; to fuel the growth of research-driven initiatives that not only drive economic prosperity but also elevate Puerto Rico to the forefront of global leadership in life sciences and technology. Our offerings are designed to support our companies at every stage of their journey, from having a physical address, incorporating their company, lab space rental and equipment access to mentorship, funding assistance, and industry partnerships. With a comprehensive suite of products and services, we aim to foster a thriving ecosystem of innovation, collaboration, and growth within the life sciences and biotechnology community. Our company’s value proposition commits to enabling an innovative approach to access to infrastructure and resources to academic institutions, researchers, startup companies, high school students and different private sectors such as pharmaceutical and medical devices companies, encouraging collaboration, economic and social development while growing the Bio-Science landscape in Puerto Rico. In summary, our incubator represents a bold step forward for Puerto Rico, offering a pathway to a sustainable and prosperous future built on the foundation of scientific excellence, collaboration, and innovation. We are committed to driving positive change and positioning Puerto Rico as a global leader in translational research.
BioFlorida, Inc.
BioFlorida — building strategic partners to innovate and accelerate progress of the Florida life science ecosystem. BioFlorida’s member driven initiatives provide a strong business climate for the advancement of innovative products and technology that improve lives and promote economic benefits to the state. Learn more about BioFlorida. | BioFlorida is the voice of Florida’s life sciences industry, representing over 8,600 establishments and research organizations in BioPharma, MedTech, Digital Health, and Health Systems that collectively employ nearly 107,000 Floridians (Source: TEConomy/BIO). BioFlorida’s member driven initiatives provide a strong climate for the advancement of innovative products and technology that improve lives and promote economic benefits to the state. | From Concept to Consumer, BioFlorida is the premier source for supporting Florida’s life sciences industry, representing a diverse range of sectors including BioPharma, MedTech, Digital Health, Health Systems, and supporting organizations. We provide comprehensive resources and advocacy while fostering a thriving community that leads in innovation, delivering groundbreaking solutions that benefit patients. BioFlorida’s value-driven membership supports the life sciences ecosystem through increased Visibility, Industry Insights, Education & Information, Networking & Events, Cost Savings, Policy & Advocacy, and Capital & Growth Opportunities. By connecting Florida’s life sciences industry with local, national, and global opportunities, BioFlorida plays a vital role in driving innovation & growth, positioning the state as a leader in the field.
Biofit Engineered Products
BioFit High Tech ESD (Electrostatic Discharge) conductive seating is tested to ANSI/ESD STM 12.1 static control standards for compliance with any S20.20 program.Since our beginning, BioFit has focused on the development of seating for technical critical-performance applications, including semiconductor, bioscience, computer and electronics manufacturing, and assembly operations. ESD stools and task chairs mitigate the risk of static electricity buildup, providing electrostatic dissipation to prevent damage to sensitive components and protect from other safety hazards in static-sensitive environments. Every unit is constructed and tested to ensure a full drain of static electricity through our conductive, specialized casters and drag chain into the floor.
Bioengineering AG
Bioengineering AG is an indipendent and autonomous company that has been successfully turning customers’ ideas into reality since 1972. We offer comprehensive solutions in the areas of Engineering & Design, Services, Plants, Bioprocess Control, Lab & Pilot, and Components. We build plants for the production of vaccines, biosimilars, starter cultures and other products and develop automation solutions and components for controlling and monitoring the plants. Over 50 years of experience in plant construction and our innovative strength enable us to successfully realise even the most complex plants. | Bioengineering AG is an independent and autonomous company that has been successfully turning customers’ ideas into reality since 1972. We offer comprehensive solutions in the areas of Engineering & Design, Services, Plants, Bioprocess Control, Lab & Pilot, and Components. We build plants for the production of vaccines, biosimilars, starter cultures and other products and develop automation solutions and components for controlling and monitoring the plants. Over 50 years of experience in plant construction and our innovative strength enable us to successfully realise even the most complex plants. | Our fields of study may be diverse, but we are all engineers at heart. And citizens of the world. Here at Bioengineering, we work for those creating and making discoveries in laboratories and production facilities around the world. What unites us with them is a certain mindset: excellence. That’s what we fly the flag for, regardless of nationality. Our claim to excellence underlines our position as an intelligent and reliable partner who, with their bioreactors and fermentors, works in collaboration with the best companies in the world: inspiring excellence.
Bioconnect Inc.
Bioconnect is a digital healthcare company specializing in AI-based, contactless biometric screening technology using remote photoplethysmography(rPPG). Using proprietary algorithms, the company makes health monitoring accessible in non-clinical settings such as public facilities, corporate wellness programs, and smart-city environments.
BIOCLONAL
BioClonal is a Spanish biotech company enabling immune responses against disease targets that were previously considered out of reach. Founded in 2022 and based in Zaragoza, BioClonal has developed a proprietary platform that unlocks the generation of high-affinity monoclonal antibodies and antigen-specific immune responses, even against the most complex or poorly immunogenic targets. Our technology can be applied in both therapeutic antibody development and next-generation vaccines, offering a versatile solution for tackling diseases with high unmet medical need. We are currently advancing a first-in-class antibody candidate for Alzheimer’s disease and are open to R&D collaborations, co-development, and licensing partnerships. BioClonal operates from its own labs and is actively engaging with pharma, biotech, and academic partners to expand the reach of its discovery engine.
BIO3S Co., Ltd
BIO3S Co., Ltd. is a biotechnology company specializing in antiviral solutions and specimen collection systems. With proprietary plant-derived virus-binding technologies, BIO3S develops products that ensure safe hygiene and accurate diagnostics, including the NORO-X Foaming Hand Soap and OralMax® Oral Specimen Collection Kit. BIO3S is a trusted supplier to public institutions and is expanding into digital healthcare. Virus-Binding Protein Technology for Hygiene and Diagnostics – BIO3S’s Dual Application in Hand Hygiene and Oral Diagnostics At the heart of BIO3S’s innovation lies its proprietary virus-binding lectin protein, extracted from sword beans (Canavalia gladiate), which demonstrates strong affinity for viral surface proteins. This powerful natural compound serves as the foundation for two of BIO3S’s flagship products: the NORO-X Foaming Hand Soap and the OralMax® Oral Specimen Collection Kit—each tailored to a different phase of viral control, from prevention to detection.
Bioagile Therapeutics Private Limited
BioAgile Therapeutics Pvt Ltd is a full fledged Clinical Research Organization based in India providing an end to end clinical research and pharmacovigilance services to pharmaceutical, nutraceutical, biotech, herbs, cosmetics and medical device industries. We have the expertise in conducting trials and have strong affiliations with multiple investigators across diverse therapeutic domains, we excel in delivering excellence from phase I to phase IV, safety, efficacy and label claims assessment. Our services also encompasses pharmacovigilance services such as case processing, signal detection, aggregate reporting and regulatory compliance. With a proven track record of conducting trials and over 120 studies successfully completed, along with 30 national and international publications, we offer unparalleled expertise. | BioAgile Therapeutics Pvt. Ltd. is a full-fledged Clinical Research Organization (CRO) based in India, offering comprehensive, end-to-end clinical research services to the pharmaceutical, nutraceutical, biotech, herbal, cosmetics, and medical device industries. We are committed to delivering scientifically robust, ethically sound, and regulatory-compliant clinical solutions tailored to meet the diverse needs of our clients. Our core services encompass the entire spectrum of clinical development—ranging from Phase I to Phase IV clinical trials. In addition, we specialize in safety, efficacy, and label claims assessment studies, particularly relevant for the nutraceutical, herbal, medical device and cosmetic segments. Our capabilities are backed by a team of experienced professionals and a strong network of investigators across a wide range of therapeutic areas. BioAgile takes pride in its proven track record, having successfully completed over 130 clinical studies to date. Our scientific contributions are further reflected in 30+ publications featured in reputed national and international journals. These accomplishments underscore our dedication to quality, data integrity, and timely project execution. With a strong focus on innovation, collaboration, and regulatory excellence, BioAgile Therapeutics continues to be a trusted partner for clinical development programs in India and globally.
BioAro
BioAro Inc. is a leading biotechnology company specializing in whole genome sequencing and advanced genetic analysis. With a strong commitment to personalized medicine, BioAro leverages cutting-edge genomic technologies to provide individuals, healthcare professionals, and researchers with comprehensive insights into genetic health, disease predisposition, and personalized wellness strategies. At the core of BioAro’s services is its whole genome sequencing platform, which delivers high-precision genetic data that empowers users to make informed health decisions. The company’s offerings extend beyond raw data by providing advanced interpretation through proprietary bioinformatics pipelines and AI-driven analytics. By transforming complex genetic information into actionable insights, BioAro enables early disease detection, risk assessment, and tailored treatment recommendations. BioAro is dedicated to bridging the gap between genomic science and real-world application by making genetic testing accessible and understandable. Its services cater to a diverse clientele, including individuals interested in proactive health management, clinicians seeking precision medicine solutions, and researchers aiming to advance genetic discoveries. The company also collaborates with pharmaceutical and healthcare organizations to support drug development and personalized therapeutics. With a focus on innovation and data security, BioAro upholds the highest standards of accuracy and confidentiality. Its state-of-the-art sequencing facilities adhere to rigorous quality controls, ensuring reliable results that users can trust. As the demand for personalized medicine grows, BioAro continues to expand its capabilities, staying at the forefront of genomic advancements to improve health outcomes and revolutionize the future of healthcare. | BioAro Inc., established in 2021, is a Canadian biotechnology company headquartered in Calgary, Alberta. The company specializes in precision health, health span, and longevity, integrating genomics, artificial intelligence (AI), and blockchain technologies to deliver personalized healthcare solutions. BioAro’s mission is to revolutionize personalized healthcare through its cutting-edge technologies, including the BioPhenome Lab, BioHealth software solutions, Biospan clinics, and biotech devices. The company’s vision focuses on extending human healthspan by integrating innovative approaches for a healthier future. BioAro operates internationally, with Headoffice in Calgary, Canada; and offices in Dubai, United Arab Emirates; and Almelo, The Netherlands, and United Kingdom reflecting its commitment to making personalized medicine accessible worldwide. BioAro aims to transform healthcare from reactive disease management to proactive health optimization, empowering individuals to take control of their health and well-being. | BioAro Inc. is a Calgary-based precision health biotechnology company advancing real-time, AI-driven multi-omics solutions for personalized medicine. Its PanOmiQ™ platform integrates genomic, epigenomic, pharmacogenomic, microbiome, and clinical data to deliver rapid, scalable insights that support early disease detection, tailored treatment strategies, and predictive healthcare. BioAro’s ecosystem improves clinical decision-making and expands precision medicine markets.